Biomarin Pharmaceutical Inc's

• BMRN's Stock Performance relative to its Competitors

Medicinova Inc Share Performance +26.36% One Year

Medicinova Inc Profile Medicinova Inc operates under a biopharmaceutical business model, primarily focused on the development and commercialization of innovative therapeutics. They strive to identify promising drug candidates with the potential to address unmet medical needs and advance them through clinical trials. By leveraging their research capabilities, strategic partnerships, and licensing opportunities, Medicinova Inc aims to bring these novel treatments to market and improve patient outcomes. More about Medicinova Inc 's Market Share

Alkermes Plc Share Performance +7.81% This Quarter

Alkermes Plc Profile Alkermes Plc is a biopharmaceutical company that focuses on the development and commercialization of innovative medicines for the treatment of central nervous system (CNS) disorders. More about Alkermes Plc 's Market Share

Beone Medicines Ltd Share Performance -2.31% Over The Past 5 Days

Beone Medicines Ltd Profile The company focuses on the discovery and development of oncology treatments for cancer patients globally. More about Beone Medicines Ltd 's Market Share

United Therapeutics Corporation Share Performance -11.26% This Quarter

United Therapeutics Corporation Profile United Therapeutics Corporation's business model revolves around the development and commercialization of innovative therapeutics for treating rare diseases and chronic conditions. They focus on researching, manufacturing, marketing, and distributing their specialized pharmaceutical and medical products to healthcare providers and patients globally. More about United Therapeutics Corporation's Market Share

Teva Pharmaceutical Industries Limited Share Performance +17.48% This Year

Teva Pharmaceutical Industries Limited Profile Teva Pharmaceutical Industries Limited is a multinational pharmaceutical company that focuses on the development, production, and marketing of generic and specialty medicines. They aim to provide affordable and accessible healthcare solutions to patients worldwide. More about Teva Pharmaceutical Industries Limited's Market Share

Sources: Biomarin Pharmaceutical Inc’s official press releases and regulatory filings; CSIMarket.com’s market research; and the financial filings and press releases of other companies cited in this report.
Updated on: Sunday, September 6, 2026 6:13 PM
Focus of this report: publicly traded companies.
For your research, we’ve provided 10 tables on Biomarin Pharmaceutical Inc versus competitors, including market share analysis.
You can find them in the navigation menu under Competition.
To download the tables, please subscribe.